Meetings International proudly announces the Global Experts Meeting on Omics Sciences and Applications which will be held during October 29-30, 2018 at Osaka, Japan. The theme of conference is “Moving to the Mastery of Omics Sciences”. Meetings International provides a Global Platform for Pharmacologist, Biotech, Medical and Healthcare Professionals to Exchange Ideas, Knowledge and Networking at its International Conference.
Meetings International provides a Global Platform for Genomics, Proteomics, Transcriptomics & allied omics sciences Professionals, Biotech, Medicine and Pharmacist Professionals to Exchange Ideas, Knowledge and Networking at its International Conference. The global Omics Sciences market is expected to reach USD 19.99 Billion by 2020 from USD 12.5 Billion in 2015, at a CAGR of 9.9%.
Omics Sciences 2018 aims to bring together researchers, Pharmacists, Medicine Specialist and delegates from Medicine, Computational biology, Bioinformatics, Pharmacy and Biochemistry fields. Meet Inspiring Speakers and Experts. The theme of conference is “Moving to the Mastery of Omics Sciences”. Omics Sciences 2018 mainly focusses on the universities, institutes, research centers and major societies along with companies which hold a big market in laboratory technologies. Target audience involves students, faculties, researchers, scientists, dean, directors and CEO's of the companies. Attend to gain an unmatched experience in the Biomedicine and Pharmacotherapy field.
Meeting International Omics Sciences Meeting will offer you an unmatched attendee experience. In addition to the many scientific sessions and take-home case study examples, you will leave this event with many other novel development strategies from some of our workshops and symposiums. Engage in dynamic conversation with your industry peers at our multiple networking sessions, and takeaway novel Biomedicine and Pharmacotherapy research strategies, which could speed up time to market and save your organization millions. We hope you will join us in Singapore Next May to enhance your research capabilities, and increase time to market on therapeutics.
CEO and Founder
Meetings International PTE LTD.
Meetings International disclose International Conference and Exhibition on “Omics Sciences and Applications” during October 29-30, 2018 Osaka, Japan. The attending delegates include Editorial Board Members of related OMICS Group Journals. This is a fabulous open door for the representatives from Universities and Institutes to communicate with the world class Scientists.
Omics Sciences 2018 Conference will be an investigation of New research Innovation of Genomics, Proteomics and Metabolomics and spread the most recent advancements and patterns in Lipidomics, Glycomics, Nutrigenomics, Pharmacogenomics, Canceromics, Metagenomics, Systems Biology, Precision Medicine, LC-MS and GC-MS Techniques, DNA microarrays, Therapeutic Metabolomics, Bioinformatics, tumor and digestion system, aging, computational biology, Mass spectrometry, and more. Omics Sciences is of interest doctors and scientist in light of the fact that it might prompt enhancements in the conclusion and medications of human illnesses. The basic aspect of these approaches is that a complex system can be understood more thoroughly if considered as a whole.
Track 1: Genomics
Genomics is the hereditary information of whole sequence of an organism including both coding and non-coding regions, encoded in DNA is known as the genome. This deals with data which is revealed by studying genetic information. The recent advances in DNA sequencing technology have modernized the sciences field, featuring unparalleled improvements in sequencing scale and implementations of various novel applications beyond genome sequencing. Genome projects, next-generation sequencing (NGS) technology provides possible applications such as whole-genome re-sequencing for variation analysis, RNA sequencing for transcriptome and non-coding RNAome analysis, quantitative detection of epigenomic dynamics, and Chip-seq analysis for DNA–protein interactions.
Track 2: Proteomics
Proteomics is the study of the structures, functions, and analysis of the expression, localizations and interactions of the proteins expressed by the genetic material of an organism. The proteome of a cell or organism is highly dynamic that undergoes many changes in different pathological and physiological states in which it exposed to. These variations are appropriately ascribed to distinctive post-transcriptional and post-translational modifications proteins undergo. The expression data shown by proteomics is clearly related to cellular activity and delivers the true picture of the cell under concern.
Track 3: Transcriptomics and Gene Prediction
Transcriptomics is the study of transcriptome the complete set of RNA transcripts which are generated by the genome under particular conditions using high-throughput techniques, for example microarray analysis. Transcriptomes comparison allows the identification of genes in distinct cell populations those are differentially expressed in response to different treatments.
Gene prediction is one of the first important steps in understanding the genome of a species after it has been sequenced. It is the process of identifying the regions of genomic DNA that encode genes, which includes both protein-coding genes and RNA genes, it also include prediction of other functional parts such as regulatory regions.
Track 4: Metabolomics and Metabonomics
Metabolomics is the large-scale study of small molecules, generally known as metabolites present in cells, bio-fluids, tissues or organisms also substrates and products of metabolism, which are influenced by both genetic and environmental factors. These small molecules and their interactions within a biological system are known as the metabolome.
Metabonomics mostly aims to measure the global, dynamic metabolic response of living systems to biological stimuli or genetic manipulation. The emphasis is on understanding systemic change through time in complex multi-cellular systems.
Track 5: Glycomics
Glycomics is the systematic study of all glycan structures of organism and comprehensive study of glycomes which includes the entire complement of sugars, free or present in more complex molecules of an organism, including genetic, physiologic and pathologic. This is a division of the glycobiology field which targets to identify the structure and functions of the complete set of glycans (glycome) produced in a cell or organism and identify all the genes that encode glycoproteins. This field includes the entire list of sugars of an organism for instance glycans attached to proteins and lipids, glycosaminoglycan and polysaccharides, containing genetic, physiologic, pathologic, and other aspects. The rapid advancement of technologies for example high-throughput mass spectrometry, glycan microarrays and carbohydrate chemistry are helping to untangle the complexity from the diverse molecules and ultimately the ‘glycan code’.
Track 6: Nutrigenomics
The interest about Nutrigenomics comes from an increasing awareness of the likely for modifications of food or diet to upkeep health and decrease the risk of diet-related diseases. It is a developing field which tends to reveal the role of nutrition on gene expression which brings together the science of bioinformatics, nutrition, molecular biology, genomics, epidemiology, and molecular medicine. This takes in known interactions between food and inherited genes, called ‘inborn errors of metabolism,’ which have long been treated by controlling the diet.
Track 7: Pharmacogenomics
Only 10% of drug molecules found make it through development in researches which means many potential drugs do not make it to the market, and expensive time and resources are invested will generate no revenue. Simulation and informatics can drastically increase these odds by improving the efficiency of drug development, cutting costs, and improving margins.
Bioinformatics is playing a progressively important role in all aspects of drug discovery, drug development and drug assessment. The increasing importance remains not only in the role which bioinformatics plays in handling large volumes of data, but also in the usefulness of bioinformatics tools to analyze, predict, interpret clinical and preclinical data and in drug target identification, validation and in the development of biomarkers and Toxicogenomics and pharmacogenomics tools to maximize the therapeutic benefit of drugs.
Track 8: Lipidomics
Lipidomics includes systems-level identification and quantitation of thousands of pathways and networks of cellular lipids molecular species and their interactions with other lipids, proteins and other moieties in vivo.
Lipidomics is a reasonable outcome of the history and traditions of lipid biochemistry and advances in mass spectrometry for understanding the roles of lipids in cellular functions. Scientist desires to understand the complexity of lipids in biology has led to new techniques which allow identifying over 1000 phospholipids in mammalian cells and tissues. Advancements in chromatographic separation and mass spectrometry for determination of the lipid composition of cells and tissues.
Track 9: Canceromics
The genomics era has brought huge advances in understanding of cancer biology and revealed the massive complexity of the cancer genome, as well as a striking heterogeneity at the whole-genome level that exists between even histologically similar tumors. The large accumulation and public availability of multi-omics databases with associated clinical annotation including tumor histology, patient response, and outcome are a rich source which has the ability to lead to fast translation of high-throughput omics to upgrade or recover overall survival.
Track 10: Computational Biology and Bioinformatics
Computational biology and bioinformatics is the field which applies and develops computational methods to analyze large collections of biological data, such as genetic sequences, cell populations or protein samples, to make new predictions or uncover new biology. The computational methods involve analytical methods, modelling and simulation. Whereas Bioinformatics is all about engineering and the creation of tools (algorithms, databases) which solve various biological problems its main is to make useful tools to work on biological data.
Computational Biology and Bioinformatics is the application of computer sciences and allied technologies to solve the query of Biologists about the secrecies of life. Computational Biology and Bioinformatics deal with application of computers in solving various biological problems. These fields are mainly concentrating on problems relating data emerging from within cells of living beings.
Track 11: System Biology
Systems biology is a research field that emphasizes on understanding entire biological systems including metabolic pathways, protein complexes and gene regulatory networks. The Bioinformatics and Systems Biology is highly interdisciplinary comprises of fields such as molecular biology, genetics, computer science, mathematics, and statistics.
The recent game-changing improvements in DNA sequencing technology have modernized the sciences field, including unique innovations in sequencing scale and novel applications beyond genome sequencing. Specifically during accelerating genome projects, next-generation sequencing (NGS) technology provides possible applications as whole-genome re-sequencing for variation analysis, RNA sequencing for transcriptome, non-coding RNAome analysis, Chip-seq analysis for DNA–protein interactions and quantitative detection of Epigenomics dynamics.
Track 12: Sequence Alignment
A sequence alignment is the arrangement of DNA, RNA, or protein sequences of to find regions of matches which can be a consequence of functional, structural, or evolutionary relationships between the sequences. When two symbolic representations of DNA or protein sequences are arranged next to one another so that their most similar elements are put together they are said to be aligned. Several bioinformatics tasks depend on successful alignments. The technique of sequence alignment is widely applied in both genomics and proteomics.
Omics is an emerging field which combines strategies to identify and quantify cellular metabolites using sophisticated analytical technologies with the application of statistical and multi-variant methods for information extraction and data interpretation. Omics consist of Genomics, Proteomics & Transcriptomics. Omics Sciences Conference deals with topics like Metagenomics, Metabolomics Bioinformatics, proteomics, systems biology, Analytical Techniques like NMR, electrospray ionization and MALDI, surface-enhanced laser desorption/ionization (SELDI). Quantitative analysis has been improved by several techniques, including differential image gel electrophoresis (DIGE), which uses fluorescent tags in gel-based techniques, and strategies of isotopically coded affinity tag (ICAT),Lipidomics, Metabolic Modelling, Metabolic profiling, clinical metabolomics, Translational sciences, Mass spectrometry, Metabolomics Syndrome, HPLC and CE based metabolomics and more. "Omics" - is a dynamic and developing field, joining genomics, transcriptomics and proteomics in empowering an integrative frameworks science methodology to drug discovery and development.
‘The Future of Omics’ gives fully fledged understanding into the compelling utilization of Genomics, Proteomics & Transcriptomics as well as advances in the techniques of biotechnology, analytical chemistry, biochemistry, and molecular biology are the source of the emergence and rapid evolution of a new omics era. The omics era has allowed the introduction and development of a medicine much more optimized and personalized, which is considered by many professionals as the medicine of the 21st century. The report also highlights the personalized medicine, healthcare and quick medical diagnostics.
Importance & Scope:
Omic technology could applied for the greater understanding of normal physiological processes and in disease processes where they play a role in screening, diagnosis and prognosis as well as understanding of the etiology of diseases.
Omic strategies is now being extensively used in biomarker discovery as they investigate multiple molecules simultaneously. Omic investigation is progressively being used in drug discovery and toxicity assessment and efficacy. Pharmacogenomics is the intersection of genomics and pharmacology which study the role of inheritance in individual variation in drug response and optimize drug therapy. Pharmacology and Omics industries are expected to grow at a high rate in coming years, which is expected to boost the growth of the market.
Why Osaka, Japan?
Japan is a world apart – a cultural Galápagos where a unique civilization blossomed, and today thrives in contrasts of traditional and modern. The Japanese spirit is strong, warm and incredibly welcoming. Japan is the second largest Life science market in the world after USA, Occupying about 10% of Market in each of the global drug and Medical devices market and a leading nation in scientific research, particularly technology, machinery and biomedical research. Japan leads the world in robotics production and use.
Scientific researchers and delegates around the world emphasis on learning about Omics Sciences and Applications.
Omic strategies provide many challenges for the evolving technology and the software and mapping the human proteome and metabolome. As Omics Sciences includes Genomics, Proteomics, Metabolomics, Lipidomics, Metagenomics, Transcriptomics, Pharmacogenomics, Canceromics and other related omics science fields. It would be a great opportunity to Access to incredible speakers and participants from different Omics science fields and companies dealing with Analytical instruments useful in these fields. Also many upcoming students and researchers can benefit themselves by participating world class International workshops, symposia during the conference which will be conducted by experts in the respective fields.
Major Omics Related Associations around the Globe:
Major Omics Related Research institutes around the Globe:
Major Omics Related Research Units in Japan:
Genomics and proteomics have greatly increased the size and feature of information about the several lesser known genetic diseases and have accelerated the cure for many diseases. Major opportunities for the market lie in the Asian markets where contract research organizations are on a rise.
The demand for genomics and proteomics technologies is increasing with the growing awareness regarding drug discovery and disease management. The growth in the genome working mechanism has influenced researchers to work in the field of rare genetic and central nervous system disease. The intensifying demand for genomics and proteomics from HIV, cancer, and diabetes diagnostics is also expected boost the growth of the market. The growth of the genomics and proteomics market is mostly driven by the increasing research funding from governments and private investors, growing demand for personalized medicine in the U.S. and Europe, and the increasing need for toxicology testing.
Fig. Research Growth of Omics Sciences
Proteomics is science with broad applications in the field of therapeutics and diagnostics. Growing R&D and emergence of new players will create more market opportunities. Most important players in this market are Thermo Fischer scientific corporation, Agilent technologies, Luminex Corporation, Sigma-Aldrich Corporation, Danaher Corporation, Bio-Rad Corporation, Waters Corporation, PerkinElmer, and Affymetrix.
The increasing investments by developing countries such as India, China, and Brazil in healthcare and medical research for drug discovery are motivating the growth of the global genomics and proteomics technology market. The global genomics and proteomics market is predictable rise at 12.1% CAGR between 2013 and 2019. The global genomics and proteomics market was valued at US$36.76 billion in 2015 and is expected to reach US$52.35 billion by the end of 2019. North America is probable to maintain the lead in the global market in terms of development in genomics and proteomics technology.
Fig. Global Market Analysis